DE3580769D1 - Zusammensetzungen und verfahren zur wundheilung. - Google Patents

Zusammensetzungen und verfahren zur wundheilung.

Info

Publication number
DE3580769D1
DE3580769D1 DE8585301127T DE3580769T DE3580769D1 DE 3580769 D1 DE3580769 D1 DE 3580769D1 DE 8585301127 T DE8585301127 T DE 8585301127T DE 3580769 T DE3580769 T DE 3580769T DE 3580769 D1 DE3580769 D1 DE 3580769D1
Authority
DE
Germany
Prior art keywords
collagen
glycosaminoglycan
suspension
present
healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585301127T
Other languages
English (en)
Inventor
Dov Michaeli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California Berkeley
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Application granted granted Critical
Publication of DE3580769D1 publication Critical patent/DE3580769D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
DE8585301127T 1984-02-24 1985-02-20 Zusammensetzungen und verfahren zur wundheilung. Expired - Lifetime DE3580769D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/583,159 US4745098A (en) 1984-02-24 1984-02-24 Compositions and method for improving wound healing

Publications (1)

Publication Number Publication Date
DE3580769D1 true DE3580769D1 (de) 1991-01-17

Family

ID=24331918

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585301127T Expired - Lifetime DE3580769D1 (de) 1984-02-24 1985-02-20 Zusammensetzungen und verfahren zur wundheilung.

Country Status (6)

Country Link
US (1) US4745098A (de)
EP (1) EP0154447B1 (de)
JP (1) JPH0751512B2 (de)
AT (1) ATE58839T1 (de)
CA (1) CA1258630A (de)
DE (1) DE3580769D1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
JPS63229068A (ja) * 1987-03-17 1988-09-22 新技術事業団 電気刺激創傷治療装置
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
US5036056A (en) * 1987-07-08 1991-07-30 Martin Kludas Methods for treating damaged corneal, uterine, or cartilage tissue
WO1989000043A1 (en) * 1987-07-08 1989-01-12 Martin Kludas Ophthalmic agent and related compositions and method for treatment of the cornea
US5055298A (en) * 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix
US4945086A (en) * 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
US5219576A (en) * 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
JP2807741B2 (ja) * 1988-12-22 1998-10-08 コレチカ リポソームの安定化方法、安定化リポソーム組成物、ならびにそれを含む医薬組成物および化粧料組成物
IE64121B1 (en) * 1989-10-04 1995-07-12 Akzo Nv Sulphated glycosaminoglycuronan with antithrombotic activity
WO1991006303A1 (en) * 1989-10-27 1991-05-16 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
AU647484B2 (en) * 1990-04-26 1994-03-24 Cytrx Corporation Composition and method for topical treatment of damaged or diseased tissue
US5500409A (en) * 1990-10-01 1996-03-19 Thomas Jefferson University Method for inhibiting collagen synthesis by keloid fibroblasts
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
PT876165E (pt) 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Composicoes de polimeros reticulados e processos para a sua utilizacao
US7883693B2 (en) 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
US6451326B2 (en) 1996-05-02 2002-09-17 Burt D. Ensley Cosmetic compositions
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
AU2002342613A1 (en) * 2001-05-09 2002-11-25 Geron Corporation Treatment for wounds
WO2004011032A1 (ja) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. 外用剤
EP1794192B1 (de) 2004-09-15 2016-05-04 Seikagaku Corporation Photovernetzbare polysaccharide, photovernetzte polysaccharidprodukte, deren verfahren zur herstellung und deren verwendung als medizinischen werkstoffe
EP1803464A4 (de) * 2004-09-17 2009-09-09 Cellgentech Inc Topisches präparat zur behandlung von hautgeschwüren
WO2006034128A2 (en) 2004-09-17 2006-03-30 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
WO2012143324A1 (en) 2011-04-19 2012-10-26 Bioiberica, S.A. Cartilage product
US9782457B2 (en) * 2011-10-07 2017-10-10 Tissue Repair Company Flowable formulations for tissue repair and regeneration
US9393278B2 (en) 2013-06-26 2016-07-19 Han Sheng Biotech Co., Ltd. Method for wound healing
CN110038115A (zh) * 2019-04-18 2019-07-23 北京和生康医疗科技有限公司 矿物质型碱性组合物及其制备方法与用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6652M (de) * 1966-12-28 1969-01-27
GB1515963A (en) * 1975-07-15 1978-06-28 Massachusetts Inst Technology Crosslinked collagen-mucopolysaccharide composite materials
US4060081A (en) * 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
FR2362632A1 (fr) * 1976-08-23 1978-03-24 Moreau Monique Nouvelles preparations pour le traitement des manifestations corporelles inesthetiques et procede de traitement
JPS6019725B2 (ja) * 1977-10-04 1985-05-17 ポ−ラ化成工業株式会社 皮膚化粧料
US4350629A (en) * 1981-07-29 1982-09-21 Massachusetts Institute Of Technology Procedures for preparing composite materials from collagen and glycosaminoglycan
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
FR2517315B1 (fr) * 1981-11-30 1985-12-20 Tech Cuir Centre Procede de preparation de formes nouvelles de collagene, natif ou dereticule, a structure helicoidale preservee, associees a des mucopolysaccharides et leurs applications notamment dans les domaines cosmetologiques, pharmaceutiques, analytiques et autres
US4448718A (en) * 1983-09-13 1984-05-15 Massachusetts Institute Of Technology Method for the preparation of collagen-glycosaminoglycan composite materials

Also Published As

Publication number Publication date
EP0154447B1 (de) 1990-12-05
JPH0751512B2 (ja) 1995-06-05
US4745098A (en) 1988-05-17
ATE58839T1 (de) 1990-12-15
JPS60222425A (ja) 1985-11-07
CA1258630A (en) 1989-08-22
EP0154447A2 (de) 1985-09-11
EP0154447A3 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
ATE58839T1 (de) Zusammensetzungen und verfahren zur wundheilung.
DE69013833T2 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
AU585268B2 (en) Inductive collagen based bone repair preparations
NZ233451A (en) Production of vascular endothelial growth factor and dna encoding same
ATE87452T1 (de) Prothese fuer meniscus.
ES2148504T3 (es) Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
KR970704459A (ko) 경조직 자극제(Hard Tissue Stimulating Agent)
EP0402740A3 (de) Reflektor für eine Leuchte und Verfahren zum Bestimmen der Form eines Reflektors
ES2104578T3 (es) Fibras individualizadas, reticuladas con acido policarboxilico.
IT8820412A0 (it) Sulfoamino derivati di condroitinsolfati, del dermatan solfato e dell'acido ialuronico e loro proprieta' farmacologiche.
DE69523585D1 (de) Wundheilmittel
ES2130268T3 (es) Preparados de acido hialuronico de bajo peso molecular, para estimulacion de formacion de huesos.
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
NZ290218A (en) Composition to reduce adhesion in wound healing
DE3689493D1 (de) Verfahren zur Herstellung von reinem natürlichen Heparansulfat und Dermatansulfat und ihre pharmazeutische Verwendung.
KR930000120A (ko) 간실질세포 증식제
DK0462194T3 (da) Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger
GB9616896D0 (en) Pharmaceutical compositions
ATE227995T1 (de) Verwendung von pseudopterosin zur förderung der wundheilung
ES2012563A6 (es) Un procedimiento pra la extraccion de sulfato de heparano de organos y tejidos de animales.
MY103079A (en) New ophtalmological composition of matter
EP0373540A3 (de) Verfahren zur Reinigung des Fibroblast-Wachstumsfaktor-Proteins
ES8207191A2 (es) Procedimiento para la preparacion de nuevos poli(h-)sulfatosde rutina y sales de los mismos
YU47599B (sh) Postupak za prečišćavanje vodenog n-metilmorfolin-n-oksidnog rastvora
ES8507000A1 (es) Metodo para la preparacion y purificacion de concentrados de factor viii antihemofilia de la sangre

Legal Events

Date Code Title Description
8364 No opposition during term of opposition